Clear Street’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Clear Street’s Portfolio AONC Stock Details AONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,196	Closed	-$22.7K	–	1350
2023 Q2	$22.7K	Buy	+2,196	New	+$22.5K	﹤0.01%	556

Other funds holding AONC

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Clear Street's AONC Position: Q3 2023 in Review

Clear Street sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q3 2023, closing a stake of 2,196 shares — an estimated $22.7K sold.

Clear Street first reported a position in AONC in Q2 2023 and held it in 1 quarter. The position peaked at $22.7K in Q2 2023. 3 funds tracked by Wall St. Rank hold AONC as of Q3 2023.

Clear Street reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Clear Street sold 2,196 American Oncology Network, Inc. Class A Common Stock shares in Q3 2023, an estimated $22.7K.
Clear Street first reported a position in American Oncology Network, Inc. Class A Common Stock in Q2 2023 and held it in 1 quarter.
Clear Street's American Oncology Network, Inc. Class A Common Stock position peaked at $22.7K in Q2 2023.
3 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q3 2023.

Based on Clear Street's 13F filing for Q3 2023, filed 13 Nov 2023.